Article Details

Vertex (VRTX) Ups Investment in CRISPR Gene Therapy Partnership

Retrieved on: 2024-05-26 17:06:08

Tags for this article:

Click the tags to see associated articles and topics

Vertex (VRTX) Ups Investment in CRISPR Gene Therapy Partnership. View article details on hiswai:

Summary

The article discusses Vertex Pharmaceuticals’ increased investment in CRISPR Therapeutics to further develop the CTX001 gene-editing therapy for sickle cell disease and beta-thalassemia. This ties to the key concept of regenerative medicine using advanced genetic engineering technologies.

Article found on: ca.style.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up